Borova Solomiia, Luxenhofer Robert
Functional Polymer Materials, Chair for Advanced Materials Synthesis, Institute for Functional Materials and Biofabrication, Department of Chemistry and Pharmacy, Julius-Maximilans-University of Würzburg, Röntgenring 11, 97070 Würzburg, Germany.
Soft Matter Chemistry, Department of Chemistry and Helsinki Institute of Sustainability Science, Faculty of Science, University of Helsinki, PO Box 55, 00014 Helsinki, Finland.
Beilstein J Org Chem. 2023 Feb 28;19:217-230. doi: 10.3762/bjoc.19.21. eCollection 2023.
For about the last ten years, poly(2-oxazoline)s have attracted significant attention as potential material for biomedical applications in, e.g., drug delivery systems, tissue engineering and more. Commonly, the synthesis of poly(2-oxazoline)s involves problematic organic solvents that are not ideal from a safety and sustainability point of view. In this study, we investigated the cationic ring-opening polymerization of 2-ethyl-2-oxazoline and 2-butyl-2-oxazoline using a variety of initiators in the recently commercialized "green" solvent dihydrolevoglucosenone (DLG). Detailed H NMR spectroscopic analysis was performed to understand the influence of the temperature and concentration on the polymerization process. Size exclusion chromatography and matrix-assisted laser desorption/ionization time-of-flight mass spectrometry were performed to determine the molar mass of the resulting polymers. Our work shows clearly that the solvent is not inert under the conditions typically used for the cationic ring-opening polymerization, as evidenced by side products and limited control over the polymerization. However, we could establish that the use of the 2-ethyl-3-methyl-2-oxazolinium triflate salt as an initiator at 60 °C results in polymers with a relatively narrow molar mass distribution and a reasonable control over the polymerization process. Further work will be necessary to establish whether a living polymerization can be achieved by additional adjustments.
在过去大约十年里,聚(2-恶唑啉)作为药物递送系统、组织工程等生物医学应用的潜在材料受到了广泛关注。通常,聚(2-恶唑啉)的合成涉及有问题的有机溶剂,从安全和可持续性角度来看并不理想。在本研究中,我们使用多种引发剂,在最近商业化的“绿色”溶剂二氢左旋葡萄糖酮(DLG)中研究了2-乙基-2-恶唑啉和2-丁基-2-恶唑啉的阳离子开环聚合反应。进行了详细的核磁共振氢谱分析,以了解温度和浓度对聚合过程的影响。进行了尺寸排阻色谱和基质辅助激光解吸/电离飞行时间质谱分析,以确定所得聚合物的摩尔质量。我们的工作清楚地表明,在阳离子开环聚合通常使用的条件下,该溶剂并非惰性,副产物和对聚合反应的有限控制证明了这一点。然而,我们可以确定,在60℃下使用三氟甲磺酸2-乙基-3-甲基-2-恶唑啉盐作为引发剂,可得到摩尔质量分布相对较窄且对聚合过程有合理控制的聚合物。通过进一步调整是否能实现活性聚合,还需要进一步的研究。